Constellation Investments’s Elevance Health ELV Stock Holding History

Constellation Investments’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$820K	Buy	5,900 +200	+4%	+$26.7K	0.15%	149
2015 Q4	$795K	Buy	5,700 +100	+2%	+$13.8K	0.15%	150
2015 Q3	$784K	Sell	5,600 -100	-2%	-$15K	0.16%	142
2015 Q2	$936K	Hold	5,700	–	–	0.18%	129
2015 Q1	$880K	Buy	5,700 +200	+4%	+$28.5K	0.17%	135
2014 Q4	$691K	Buy	5,500 +200	+4%	+$24.7K	0.14%	162
2014 Q3	$634K	Hold	5,300	–	–	0.14%	162
2014 Q2	$570K	Hold	5,300	–	–	0.13%	180
2014 Q1	$528K	Sell	5,300 -100	-2%	-$9.04K	0.13%	187
2013 Q4	$499K	Buy	5,400 +300	+6%	+$26.7K	0.13%	182
2013 Q3	$426K	Buy	5,100 +300	+6%	+$25.7K	0.13%	183
2013 Q2	$393K	Buy	+4,800	New	+$359K	0.14%	176

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Constellation Investments's ELV Position: Q1 2016 in Review

Constellation Investments increased its Elevance Health (ELV) stake by 3.5% in Q1 2016, buying an estimated $26.7K and bringing the position to 5,900 shares worth $820K. The position accounts for 0.15% of the portfolio, ranked #149.

Constellation Investments first reported a position in ELV in Q2 2013 and has held it in 12 quarters since. The position peaked at $936K in Q2 2015. 772 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

Constellation Investments held 5,900 shares of Elevance Health worth $820K as of Q1 2016.
Constellation Investments bought 200 Elevance Health shares in Q1 2016, an estimated $26.7K.
Elevance Health made up 0.15% of Constellation Investments's portfolio in Q1 2016, its #149 holding.
Constellation Investments first reported a position in Elevance Health in Q2 2013 and has held it in 12 quarters since.
Constellation Investments's Elevance Health position peaked at $936K in Q2 2015.
772 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.